SQUAWK/NEWS
Menu
Live News EQUITY M impact

Cartesian Therapeutics 8K Filing

Cartesian Therapeutics files 8K with material agreements and executive changes. The filing includes unregistered sales of equity securities and financial statements.

CRTX

Filed: 2026-05-26 AccNo: 0001453687-26-000087 Size: 5 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 3.02: Unregistered Sales of Equity Securities Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits